Sign Out
KOACT is an antibiotic agent with a notably broad spectrum of activity against bacteria which are sensitive to amoxicillin and non-sensitive to amoxicillin due to the β-lactamase inhibitory action of clavulanate in the formula.
KOACT oral preparations are indicated for short-term treatment of bacterial infections caused by amoxicillin resistant β-lactamase-producing strains or when amoxicillin alone is not effective, at the following sites: Upper Respiratory Tract Infections (including ENT): e.g. sinusitis, otitis media.
Lower Respiratory Tract Infections: e.g. acute exacerbations of chronic bronchitis, bronchopneumonia.
Genito-urinary Tract Infections: e.g. cystitis.
Skin and Soft Tissue Infections: e.g. cellulitis caused by E. coli, Klebsiella and Enterobacter spp.
Mixed infections caused by amoxicillin-susceptible organisms in conjunction with Co-amoxiclav-susceptible β-lactamase-producing organisms may be treated with KOACT.
Continue with Google